Consorzio Interuniversitario Nazionale per la Bio-Oncologia (CINBO)
PROGRAM
si ringrazia per il contributo incondizionato:
FOCUS ON MELANOMA AND NON-MELANOMA SKIN CANCER
CINBO
La partecipazione è gratuita.
Per accedere al Webinar collegarsi a
www.strategieonweb.it/ecm/focus-on-melanoma-and-non-melanoma-skin-cancer-fad/
L’attestato di attribuzione dei crediti ottenuti, sarà inviato ai partecipanti, dopo aver verificato il completamento del percorso formativo ed il superamento della verifica di apprendimento.
May 6-7, 2021
PROVIDER ECM ID. 50 PROVIDER ECM ID. 50 ORGANIZING ORGANIZING SECRETARIAT SECRETARIAT
Via Piave 110/7 - Pescara Phone: +39 085 74143
Fax +39 085 378220 [email protected] www.strategieonweb.it
OFFICES OFFICES
Consorzio Interuniversitario Nazionaleper la Bio-Oncologia (CINBO) c/o Sezione di Oncologia Medica Università G. D’Annunzio
Via dei Vestini, 31 66100 Chieti - Italy Phone: +39 0871 3556732 Fax +39 0871 3556707 [email protected]
Con il patrocinio di:
Evento n. ECM 50-315652 Per Medico Chirurgo specialisti in:
ALLERGOLOGIA ED IMMUNOLOGIA CLINICA; DERMATOLOGIA E VENEREOLOGIA; GENETICA MEDICA;
RADIODIAGNOSTICA; ONCOLOGIA; RADIOTERAPIA; CHIRURGIA PLASTICA E RICOSTRUTTIVA;
ANATOMIA PATOLOGICA; MEDICINA NUCLEARE; Per Farmacisti (Farmacia ospedaliera); Per Biologi.
Crediti ECM: 6
WEBINAR
Directors Directors Paolo Amerio Michele De Tursi Clara Natoli
Test ECM sarà su piattaforma on line a partire dalle 24h dal termine del corso e resterà attivo per 48h su www.strategieonweb.it/fad/
May 6, 2021 May 7, 2021
SESSION I SESSION I
INTRODUCTION AND EARLY STAGES INTRODUCTION AND EARLY STAGES Moderators:
Maria Concetta Fargnoli - Consiglia Carella - Gianluca Proietto 14.00 Open on website www.strategieonweb.it/fad/
15.00 Lecture: Future perspectives on immunotherapy Massimo Guidoboni, Meldola
15.30 Diagnosis, surgery and staging in Melanoma 2021 Eduarde Nagore, Valencia, Spain
16.00 Targeted therapies in the adjuvant setting for BRAF+ melanoma patients
Antonio Maria Grimaldi, Napoli 16.20 Questions and answers
16.40 Immunotherapy in the adiuvant setting for melanoma patients
Michele De Tursi, Chieti 17.00 Questions and answers SESSION II
SESSION II
THE METASTATIC SETTING THE METASTATIC SETTING
Moderators: Corrado Ficorella - Michele De Tursi
17.10 Management and targeted treatments for metastatic BRAF+ melanoma patients
Riccardo Marconcini, Pisa 17.30 Questions and answers
17.40 Immunotherapy in metastatic melanoma Anna Maria Di Giacomo, Siena 18.00 Questions and answers
18.10 Toxicity management of systemic therapies Elisabetta Gambale, Florence
18.30 Questions and answers 18.40 - 18.50
Concluding remarks
Paolo Amerio – Michele De Tursi – Clara Natoli 14.00 Open on website www.strategieonweb.it/fad/
15.00 Welcome and Introduction
Paolo Amerio – Michele De Tursi – Clara Natoli SESSION I
SESSION I
BASAL CELL AND SQUAMOUS CELL SKIN CANCERS BASAL CELL AND SQUAMOUS CELL SKIN CANCERS Moderators: Paolo Amerio – Dimitri Luisi
15.10 Diagnosis, surgery, prognostic factors and staging work-up: updated recommendations
Pietro Quaglino, Torino 15.30 Questions and answers
15.40 The current role of radiotherapy: techniques, indications and outcomes
Maria Taraborrelli, Chieti 16.00 Questions and answers
16.10 Update in the systemic treatment of basal cell carcinoma Cortellini Alessio, L’Aquila-London
16.30 Questions and answers
16.40 Systemic treatment approach: the new standard of care for advanced squamous cell carcinoma
Mario Mandalà, Perugia 17.00 Questions and answers SESSION II
SESSION II
MERKEL CARCINOMA MERKEL CARCINOMA
Moderators: Nicola D’Ostilio - Massimo Amatetti 17.10 Diagnosis, surgery, prognostic factors and staging
work-up: updated recommendations Giulio Gualdi, Chieti
17.30 Questions and answers
17.40 Systemic treatment approach in metastatic Merk carcinoma: the first line and beyond
Marco Platania, Milan 18.00 Questions and answers 18.10 - 18.20
Concluding remarks 1° day
Paolo Amerio – Michele De Tursi – Clara Natoli el
